XML 34 R23.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Derivative Financial Instruments (Tables) | 9 Months Ended
--- | ---
Oct. 01, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule Of Fair Values Of The Company's Derivative Instruments And The Line Items On The Consolidated Balance Sheets | The fair values of the Company’s derivative instruments and the line items on the unaudited condensed consolidated balance sheets to which they were recorded as of October 1, 2017 and December 31, 2016 are summarized as follows:
Derivative Assets |  | Balance Sheet Location |  | Fair Value at October 1, 2017 |  | Balance Sheet Location |  | Fair Value at December 31, 2016
|  |  |  | (In thousands) |  |  |  | (In thousands)
Derivative assets not designated as hedging instruments |  | Prepaid expenses and other current assets |  | $ | 1,184 |  |  | Prepaid expenses and other current assets |  | $ | 5,873 |
Derivative assets designated as hedging instruments |  | Prepaid expenses and other current assets |  | 1,356 |  |  | Prepaid expenses and other current assets |  | 2,890 |
Total |  |  |  | $ | 2,540 |  |  |  |  | $ | 8,763 |
Derivative Liabilities |  | Balance Sheet Location |  | Fair Value at October 1, 2017 |  | Balance Sheet Location |  | Fair Value at December 31, 2016
|  |  |  | (In thousands) |  |  |  | (In thousands)
Derivative liabilities not designated as hedging instruments |  | Other accrued liabilities |  | $ | 5,547 |  |  | Other accrued liabilities |  | $ | 1,002 |
Derivative liabilities designated as hedging instruments |  | Other accrued liabilities |  | 6,202 |  |  | Other accrued liabilities |  | 703 |
Total |  |  |  | $ | 11,749 |  |  |  |  | $ | 1,705 |
Schedule of Offsetting of Derivative Assets | The following tables set forth the offsetting of derivative assets as of October 1, 2017 and December 31, 2016:
As of October 1, 2017 |  |  |  |  |  |  |  | Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets |  |
| Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheets |  | Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Net Amount
|  | (In thousands)
Bank of America |  | $ | 2,038 |  |  | $ | — |  |  | $ | 2,038 |  |  | $ | (2,038 | ) |  | $ | — |  |  | $ | — |
Wells Fargo |  | 502 |  |  | — |  |  | 502 |  |  | (502 | ) |  | — |  |  | — |
Total |  | $ | 2,540 |  |  | $ | — |  |  | $ | 2,540 |  |  | $ | (2,540 | ) |  | $ | — |  |  | $ | — |
As of December 31, 2016 |  |  |  |  |  |  |  | Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets |  |
| Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheets |  | Net Amounts Of Assets Presented in the Condensed Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Net Amount
|  | (In thousands)
J.P. Morgan Chase |  | $ | 1,492 |  |  | $ | — |  |  | $ | 1,492 |  |  | $ | (442 | ) |  | $ | — |  |  | $ | 1,050 |
Wells Fargo |  | 7,271 |  |  | — |  |  | 7,271 |  |  | (1,263 | ) |  | — |  |  | 6,008 |
Total |  | $ | 8,763 |  |  | $ | — |  |  | $ | 8,763 |  |  | $ | (1,705 | ) |  | $ | — |  |  | $ | 7,058 |
Schedule of Offsetting of Derivative Liabilities | The following tables set forth the offsetting of derivative liabilities as of October 1, 2017 and December 31, 2016:
As of October 1, 2017 |  |  |  |  |  |  |  | Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets |  |
| Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheets |  | Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Net Amount
|  | (In thousands)
Bank of America |  | $ | 11,113 |  |  | $ | — |  |  | $ | 11,113 |  |  | $ | (2,038 | ) |  | $ | — |  |  | $ | 9,075 |
Wells Fargo |  | 636 |  |  | — |  |  | 636 |  |  | (502 | ) |  | — |  |  | 134 |
Total |  | $ | 11,749 |  |  | $ | — |  |  | $ | 11,749 |  |  | $ | (2,540 | ) |  | $ | — |  |  | $ | 9,209 |
As of December 31, 2016 |  |  |  |  |  |  |  | Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets |  |
| Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Condensed Consolidated Balance Sheets |  | Net Amounts Of Liabilities Presented in the Condensed Consolidated Balance Sheets |  | Financial Instruments |  | Cash Collateral Pledged |  | Net Amount
|  | (In thousands)
J.P. Morgan Chase |  | $ | 442 |  |  | $ | — |  |  | $ | 442 |  |  | $ | (442 | ) |  | $ | — |  |  | $ | — |
Wells Fargo |  | 1,263 |  |  | — |  |  | 1,263 |  |  | (1,263 | ) |  | — |  |  | — |
Total |  | $ | 1,705 |  |  | $ | — |  |  | $ | 1,705 |  |  | $ | (1,705 | ) |  | $ | — |  |  | $ | — |
Schedule Of Company's Derivative Instruments On Other Comprehensive Income And The Consolidated Statement Of Operations | The pre-tax effects of the Company’s derivative instruments on OCI and the unaudited condensed consolidated statement of operations for the three and nine months ended October 1, 2017 and October 2, 2016 are summarized as follows:
Derivatives Designated as Hedging Instruments |  | Three Months Ended October 1, 2017
| Gains (Losses) Recognized in OCI - Effective Portion |  | Location of Gains (Losses) Reclassified from OCI into Income - Effective Portion |  | Gains (Losses) Reclassified from OCI into Income - Effective Portion (1) |  | Location of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing |  | Amount of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing
|  | (In thousands)
Cash flow hedges: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | (3,538 | ) |  | Net revenue |  | $ | (4,401 | ) |  | Other income (expense), net |  | $ | 528 |
Foreign currency forward contracts |  | — |  |  | Cost of revenue |  | 19 |  |  | Other income (expense), net |  | — |
Foreign currency forward contracts |  | — |  |  | Operating expenses |  | 822 |  |  | Other income (expense), net |  | — |
Total |  | $ | (3,538 | ) |  |  |  | $ | (3,560 | ) |  |  |  | $ | 528 |
_________________________ (1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Derivatives Designated as Hedging Instruments |  | Nine Months Ended October 1, 2017
| Gains (Losses) Recognized in OCI - Effective Portion |  | Location of Gains (Losses) Reclassified from OCI into Income - Effective Portion |  | Gains (Losses) Reclassified from OCI into Income - Effective Portion (1) |  | Location of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing |  | Amount of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing
|  | (In thousands)
Cash flow hedges: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | (10,590 | ) |  | Net revenue |  | $ | (3,374 | ) |  | Other income (expense), net |  | $ | 1,196 |
Foreign currency forward contracts |  | — |  |  | Cost of revenue |  | 5 |  |  | Other income (expense), net |  | — |
Foreign currency forward contracts |  | — |  |  | Operating expenses |  | 457 |  |  | Other income (expense), net |  | — |
Total |  | $ | (10,590 | ) |  |  |  | $ | (2,912 | ) |  |  |  | $ | 1,196 |
_________________________ (1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Derivatives Designated as Hedging Instruments |  | Three Months Ended October 2, 2016
| Gains (Losses) Recognized in OCI - Effective Portion |  | Location of Gains (Losses) Reclassified from OCI into Income - Effective Portion |  | Gains (Losses) Reclassified from OCI into Income - Effective Portion (1) |  | Location of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing |  | Amount of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing
|  | (In thousands)
Cash flow hedges: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | (417 | ) |  | Net revenue |  | $ | (824 | ) |  | Other income (expense), net |  | $ | 116 |
Foreign currency forward contracts |  | — |  |  | Cost of revenue |  | 4 |  |  | Other income (expense), net |  | — |
Foreign currency forward contracts |  | — |  |  | Operating expenses |  | 163 |  |  | Other income (expense), net |  | — |
Total |  | $ | (417 | ) |  |  |  | $ | (657 | ) |  |  |  | $ | 116 |
_______________________ (1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Derivatives Designated as Hedging Instruments |  | Nine Months Ended October 2, 2016
| Gains (Losses) Recognized in OCI - Effective Portion |  | Location of Gains (Losses) Reclassified from OCI into Income - Effective Portion |  | Gains (Losses) Reclassified from OCI into Income - Effective Portion (1) |  | Location of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing |  | Amount of Gains (Losses) Recognized in Income and Excluded from Effectiveness Testing
|  | (In thousands)
Cash flow hedges: |  |  |  |  |  |  |  |  |  |
Foreign currency forward contracts |  | $ | (1,116 | ) |  | Net revenue |  | $ | (1,543 | ) |  | Other income (expense), net |  | $ | 169 |
Foreign currency forward contracts |  | — |  |  | Cost of revenue |  | 4 |  |  | Other income (expense), net |  | — |
Foreign currency forward contracts |  | — |  |  | Operating expenses |  | 219 |  |  | Other income (expense), net |  | — |
Total |  | $ | (1,116 | ) |  |  |  | $ | (1,320 | ) |  |  |  | $ | 169 |
_________________________ (1) Refer to Note 9, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.
Schedule Of Derivatives Not Designated As Hedging Instruments | The effects of the Company’s non-designated hedge included in other income (expense), net in the unaudited condensed consolidated statements of operations for the three and nine months ended October 1, 2017 and October 2, 2016 are as follows:
Derivatives Not Designated as Hedging Instruments |  | Location of Gains (Losses) Recognized in Income on Derivative |  | Three Months Ended |  | Nine Months Ended
| October 1, 2017 |  | October 2, 2016 |  | October 1, 2017 |  | October 2, 2016
|  |  |  | (In thousands)
Foreign currency forward contracts |  | Other income (expense), net |  | $ | (1,925 | ) |  | $ | (493 | ) |  | $ | (6,171 | ) |  | $ | (1,252 | )

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312 + Details
Name: | us-gaap_OffsettingAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 + Details
Name: | us-gaap_OffsettingLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in cash flow hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration